Accumulation of amyloid β (Aβ) peptides constitutes the neuropathological hallmark of Alzheimer’s disease(AD). According to the amyloid hypothesis, the accumulation of Aβ results in progressive loss of synaptic efficacy. K+ channels regulate a number of processes: the resting potential, keeping action potentials short, timing interspike intervals and synaptic plasticity1. A number of studies have shown that Aβ alters properties of K+ currents in neurons2,3,4. We have previously reported a possible physiological role for the soluble Aβ1-40 peptide in modulating ‘A’-type K+ channels in cerebellar granule neurons3,4. In this study we use organotypic hippocampal slices to mimic the in vivo modulation of K+ channels by soluble rat recombinant Aβ1-40 over 24 hours. Whole-cell patch clamp measurements of K+ channel currents were carried out using organotypic hippocampal slices prepared from 8-10 day old rats using the Stoppini method5. The extracellular solution contained aCSF consisting of (mM): 126 NaCl,3KCl,1.25NaH2PO4,2MgSO4, 2CaCl2.2H20,10 glucose and 24 NaHCO3. Intracellular solution contained (mM): 140KCl, 0.5CaCl2, 5EGTA, 10HEPES and 2K-ATP. Rat recombinant Aβ1-40 was solubilised in DMSO before dilution in culture media to a concentration of 10nM and applied to slices for 24 hours. The reverse Aβ40-1 peptide was used as control. Statistical differences were assessed using repeated measures ANOVA with Tukey’s post-hoc test or an unpaired Student’s t-test. Rat recombinant Aβ1-40 caused a significant 3.5 fold increase in the peak K+ channel current density/voltage (I-V) relationship in slices (n=6 controls, n=7 Aβ-treated cells). At a test potential of +50mV, current increased from 20.0±0.01 pA/pF in the control to 90.0±0.02pA/pF. Peak K+ channel current was further separated by their inactivation properties into fast inactivating ‘A’-type(IKA) and non-inactivating delayed rectifier (IKV) components. In order to isolate the two components, cells were prepulsed to a potential of -140mV and measurements of the peak current was subtracted from the current at the end of the test step (peak-end). The IKA component of the K+ current I-V was particularly sensitive to the effects of rat recombinant Aβ1-40, with a significant 5 fold increase in K+ channel current density when compared to the control. At a test potential of +50mV, current increased from 5.0±0.01 pA/pF in the control to 30.0±0.01 pA/pF in Aβ-treated cells. There was no significant difference in IKV. The data from this study corroborate our previous findings, supporting a physiological role for the Aβ1-40 peptide as a modulator of K+ channels, in particular the IKA component. IKA channels have been implicated in the onset of LTP in neurons, which is thought to underlie learning and memory1. A disruption in this physiological modulation may therefore result in a disruption of synaptic plasticity, classic to AD.
University of Cambridge (2008) Proc Physiol Soc 11, C44
Oral Communications: Alzheimer’s Disease: A result of the deterioration in K+ channel homeostasis?
T. L. Kerrigan1,2, C. Peers1, H. A. Pearson2
1. Division of Cardiovascular and Neuronal Remodelling, University of Leeds, Leeds, United Kingdom. 2. Institute of Membrane and Systems Biology, University of Leeds, Leeds, United Kingdom.
View other abstracts by:
Where applicable, experiments conform with Society ethical requirements.